CASM - CAS Medical Systems, Inc.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
2.4500
0.0000 (0.00%)
At close: 4:00PM EDT
Stock chart is not supported by your current browser
Previous Close2.4500
Open2.4400
Bid0.0000 x 1300
Ask0.0000 x 1000
Day's Range2.4400 - 2.4500
52 Week Range1.3300 - 2.7000
Volume64,728
Avg. Volume114,168
Market Cap68.728M
Beta (3Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Benzinga3 months ago

    CAS Medical Surges As Edwards Lifesciences Agrees To Buy Medtech Company In $100M Deal

    CAS Medical is a medical tech company that focuses on non-invasive monitoring of tissue oxygenation in the brain. Edwards will buy CAS Medical in an all-cash transaction for $2.45 per share, or an equity value of about $100 million, according to the terms of the deal.

  • Should You Worry About CAS Medical Systems, Inc.’s (NASDAQ:CASM) CEO Pay Cheque?
    Simply Wall St.4 months ago

    Should You Worry About CAS Medical Systems, Inc.’s (NASDAQ:CASM) CEO Pay Cheque?

    Tom Patton became the CEO of CAS Medical Systems, Inc. (NASDAQ:CASM) in 2010. This report will, first, examine the CEO compensation levels in comparison to CEO compensation at companies of Read More...

  • Zacks Small Cap Research4 months ago

    CASM: Q4 2019 Preannouncement, Initial 2019 Guidance, OEM Cable Launch Expected Mid-2019

    Post-market close yesterday, CAS Medical (CASM) released preliminary Q4 revenue and monitor placement numbers and provided initial (general) guidance for how they think 2019 may shape up. Note, however, that this current 2019 guidance, of low double-digit FORE-SIGHT sales growth (inline with our prior and current estimates), does not include any potential contribution from their OEM smart cable product – which management now thinks will launch around mid-year. Company guidance will be updated following the launch.

  • A Look At The Fair Value Of CAS Medical Systems Inc (NASDAQ:CASM)
    Simply Wall St.6 months ago

    A Look At The Fair Value Of CAS Medical Systems Inc (NASDAQ:CASM)

    In this article I am going to calculate the intrinsic value of CAS Medical Systems Inc (NASDAQ:CASM) by estimating the company’s future cash flows and discounting them to their present Read More...

  • Thomson Reuters StreetEvents6 months ago

    Edited Transcript of CASM earnings conference call or presentation 31-Oct-18 2:00pm GMT

    Q3 2018 CAS Medical Systems Inc Earnings Call

  • Zacks Small Cap Research6 months ago

    CASM: Competitive Wins Resulting in Accelerating Consumable Revenue, Rapidly Improving Profitability

    Another solid quarter turned in by CAS Medical (CASM) with total revenue jumping 19% yoy and about 2% better than Q2. The combination of revenue growth and effective expense-control initiatives have pushed operating loss lower by an average of ~$150k each quarter since Q1 2017. Importantly, despite the recently instituted trade tariffs, management is guiding for reaching cash flow break even by the end of 2019 (and possibly sooner if the tariffs are lifted).

  • Investopedia9 months ago

    Penny Stocks to Watch for September 2018

    Junior miners turned lower in sympathy with declining gold and silver contracts, while small biotech and medical diagnostic stocks picked up the slack, underpinned by sector funds probing new highs. September has a mixed reputation when it comes to small speculative plays, suggesting that traders focus their attention on penny stocks exhibiting the highest relative strength while avoiding falling knives that may face tax selling pressure in the fourth quarter. Low-priced energy stocks look like wild cards in this equation, with crude oil coming off lows while rising Middle East tensions add to sector buying power.

  • Thomson Reuters StreetEvents9 months ago

    Edited Transcript of CASM earnings conference call or presentation 2-Aug-18 2:00pm GMT

    Q2 2018 CAS Medical Systems Inc Earnings Call

  • Zacks Small Cap Research9 months ago

    CASM: FORE-SIGHT Momentum Continues, Moving PT to $4.50/share

    The FORE-SIGHT business, particularly as it relates to the U.S. market, continues to impress. The U.S. installed base expanded by 25% yoy during the first half of 2018 and domestic sensor sales have now set new record highs for three consecutive quarters. U.S. FORE-SIGHT revenue grew by an average of 20% yoy over the last three quarters (including 20% in Q2).

  • Investopedia10 months ago

    Penny Stocks to Watch for August 2018

    Penny stock pickers booked modest returns in these tough conditions, while trend followers and dart throwers took losses. The July penny stock list generated mixed returns, with precious metals and biotech headwinds limiting gains while a mid-month crude oil reversal undermined small energy plays.